Urogenital Tract Infection

Table. 3.

Associations between clinical parameters and infectious complications after transurethral surgery and multivariate analysis of clinical parameters independently affecting infectious complications after transurethral surgery

Univariate analysis (n=643)
Variables Unadjusted OR (95% CI) p-value
Age 1.07 (1.02-1.13) 0.010
BMI 0.94 (0.84-1.06) 0.296
DM 1.72 (0.82-3.59) 0.150
Immunosuppression - 0.990
Foley catheterization before surgery 1.25 (0.50-3.13) 0.628
Urinary retention 0.77 (0.31-1.91) 0.571
Prostate volume 1.01 (0.99-1.02) 0.325
IPSS 0.95 (0.89-1.01) 0.085
Co-op Hx with prostate surgery 0.86 (0.30-2.51) 0.783
Resected prostate volume 1.01 (0.99-1.03) 0.166
Operative duration (min) 1.00 (0.99-1.01) 0.347
Duration of Foley catheterization (d) 1.15 (1.06-1.24) 0.001
Antibiotic use for more than one day 0.717 (0.33-1.54) 0.395
OP method (reference; HOLEP)
TURP 0.82 (0.39-1.70) 0.588
KTP 1.77 (0.22-14.6) 0.595
Type of antibiotics (reference; 1st cephalosporin)
2nd cephalosporin 1.52 (0.35-6.59) 0.577
3rd cephalosporin 1.06 (0.09-12.2) 0.963
Quinolone 0.87 (0.12-6.38) 0.890
Others 1.47 (0.19-10.9) 0.705
Multivariate analysis (n=643)
Adjusted OR
(95% CI)
p-value
Age 1.05 (0.99-1.11) 0.073
Duration of Foley catheterization (d) 1.13 (1.04-1.23) 0.003

OR: odds ratio, CI: confidence interval, BMI: body mass index, DM: diabetes mellitus, IPSS: International Prostate Symptom Score, OP: operation, Hx: history, TURP: transurethral resection of the prostate, HOLEP: Holmium laser enucleation of the prostate, KTP: pota-ssium-titanyl-phosphate.

Urogenit Tract Infect 2022;17:81-8 https://doi.org/10.14777/uti.2022.17.3.81
© 2022 Urogenit Tract Infect